Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC I Acquisition A | ASCA | Mar 20, 2023 | 10.33 | 0.00 |
A SPAC I Acquisition Corp. - Unit | ASCAU | Mar 20, 2023 | 10.48 | 0.00 |
A SPAC II Acquisition | ASCB | Mar 20, 2023 | 10.40 | +0.39 |
A SPAC II Acquisition Corp. - Unit | ASCBU | Mar 20, 2023 | 10.42 | 0.00 |
A-Mark Precious Metals | AMRK | Mar 20, 2023 | 29.78 | -0.12 |
a.k.a Brands | AKA | Mar 20, 2023 | 0.70 | -20.82 |
A.O Smith | AOS | Mar 20, 2023 | 66.45 | +1.50 |
A10 Networks | ATEN | Mar 20, 2023 | 14.61 | +1.46 |
A2Z Smart Technologies Corp. - | AZ | Mar 20, 2023 | 1.26 | +1.61 |
AAA - A Rated Corporate Bond Ishares | QLTA | Mar 20, 2023 | 47.19 | -0.27 |
Aadi Bioscience | AADI | Mar 20, 2023 | 7.59 | +0.93 |
AAON | AAON | Mar 20, 2023 | 89.79 | +0.51 |
AAR Corp. | AIR | Mar 20, 2023 | 51.86 | +2.41 |
Aarons | AAN | Mar 20, 2023 | 9.38 | -0.85 |
ABB | ABB | Mar 20, 2023 | 32.56 | +1.78 |
Abbott Laboratories | ABT | Mar 20, 2023 | 97.87 | +0.89 |
AbbVie | ABBV | Mar 20, 2023 | 156.12 | +1.23 |
Abcam ADR | ABCM | Mar 20, 2023 | 13.42 | -3.73 |
AbCellera Biologics | ABCL | Mar 20, 2023 | 7.57 | +2.44 |
Abeona Therapeutics | ABEO | Mar 20, 2023 | 2.30 | -3.77 |
Abercrombie & Fitch | ANF | Mar 20, 2023 | 26.06 | +0.39 |
Aberdeen Asia-Pacificome Fund | FAX | Mar 20, 2023 | 2.65 | -0.75 |
Aberdeen Australia Equity Fund | IAF | Mar 20, 2023 | 4.28 | -0.93 |
Aberdeen Emerging Markets | AEF | Mar 20, 2023 | 5.05 | +0.80 |
Aberdeen Global | FCO | Mar 20, 2023 | 5.07 | -0.99 |
Aberdeen Income Credit Strategies | ACP | Mar 20, 2023 | 6.75 | -0.88 |
Aberdeen Income Credit Strategies Pref | ACP-A | Mar 20, 2023 | 21.18 | +0.47 |
Aberdeen Japan Equity | JEQ | Mar 20, 2023 | 5.33 | +0.19 |
Aberdeen Standard Global Infrastructure | ASGI | Mar 20, 2023 | 17.41 | +0.23 |
ABG Acquisition I A | ABGI | Mar 20, 2023 | 10.19 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.